The Evaluation of “Intraderm Sulphur” for Acne Vulgaris12  by MacKee, George M. et al.
THE EVALUATION OF "INTRADERM SULPHUR" FOR ACNE VUL-
GARIS12
GEORGE M. MACKE, JACOB WACHTEL, FLORENTINE L. KARP AND
FRANZ HERRMANN
During the past four and one half years a new group of liquid vehicles was
developed by means of which it was possible to carry a variety of substances
into intact human and animal skin. After preliminary studies on penetration
into colloid models (1) consisting of protein and fatty media, successful attempts
were made to demonstrate the effect of these liquid vehicles histologically (2,
3, 4) and to compare the results under like conditions with those of conventional
vehicles. MacKee, Su1berger, Herrmann, and Baer found as a result of these
investigations that one particular combination consisting of interface active
agents (alkyl benzene sodium sulfonate mixture), coupling agent and solubilizer
(antipyrine), organic solvent (propylene glycol) and water, served best to obtain
extensive skin impregnation. It was demonstrated that the main pathway for
the different substances carried by means of this vehicle, called "Intraderm",
was through the pilo-sebaceous apparatus from the outside into the derma and
then into the epidermis.
In addition to the above mentioned experiments in vitro and histo-chemical
and physio-chemical studies of the vehicle properties, extensive clinical trials
were made demonstrating the penetration of protein allergens when inuncted
with "Intraderm" on the unbroken skin of individuals suffering from atopic
dermatitis (5). The same investigators shoned that frequent repetition of such
inunctions carried out in some cases daily for a period of many months or sev-
eral years, did not produce any inflammatory changes even in allergic and atopic
patients (6).
Three years ago, we began the clinical evaluation of the newly developed
vehicle in combination with sulphur for the treatment of acne vulgaris.
As was the case with each single drug to be used with "Intraderm", the in-
corporation of sulphur required certain modifications in the quantitative pro-
portions of the vehicle constituents, and the addition of a special solvent agent,
in order to obtain proper solubility, without interfering with the tolerability of
the preparation. Triethanolamine proved to be a suitable solvent. When this
organic base acts on precipitated sulphur, a soluble and active polysulfide is
formed. The following formula gives the composition of the new preparation
("Intraderm Sulphur").
Sulphur 7.5
Sodium mixed alkyl benzene sulfonate 110.
Antipyrine 54.
Triethanolamine 100.
Propylene glycol 560.
Water 168.5
1000.00 weight parts
1 Received for publication July 12, 1945, from The New York Skin and Cancer Unit,
New York Post-Graduate Medical School and Hospital, Columbia University, New York
City.
2 This research was made possible by a grant from the Wallace Laboratories, Inc., New
Brunswick, New Jersey.
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Fm. 1. ACNE CTSTICA: BEFoRE TREATMENT, 16 YRAJtS OF AGE
Before treatment with Intraderm Sulfur. Duration of acne: 3 years. Previous treat-
ment: Ultra violet radiation, lotio alba, diet, Vlemingkx's sol., vitamin A.
This combination gives a homogeneous, clear solution resembling oily liquids
in appearance and consistency.
"N
.7.
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It was to be expected that a Chemical SO readily undergoing oxidizing and re-
ducing reactions with organic matter as the described polysulfide, would com-
bine per se with some of the superficial layers of the skin, more specifically the
upper horny layer, and then exert therapeutic action in some less superficial
Fm. 2. Same patient shown in Fig. 1 after 4 months of treatment with Intraderm Sulfur
structures. In principle this mode of action has been utilized similarly with our
older preparations containing alkali-polysulfide. Enhanced efficiency, however,
was to be expected from the use of the new formula, since the active ingredient
could be assumed to reach the diseased sites in a much greater quantity and even
selectively, namely the entire length of the follicles and sebaceous glands.
t
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CLINICAL EFFECTS
Sulphur in some form has been used in the treatment of acne vulgaris for
many years. As is the case with any sulphur preparation employed in the treat-
ment of acne vulgaris, some erythema and desquamation usually occur before
any improvement is noted. It is even possible that no success can be attained
without some hyperemia and some keratolytic action.
We anticipated a greater degree of erythema and desquam:. ion from the
use of the new remedy, because of the extensive impregnation of the skin with
sulphur, but this occurred as a rule only if the preparation was too frequently
applied. We believe therefore that the mode of action of this preparation does
not differ materially from the mode of action of the commonly used sulphur
preparations in the treatment of acne vulgaris.
MODE OF APPLICATION
At the commencement of this investigation patients were instructed to apply
the remedy on a piece of linen. Subsequently, it was deemed advisable to have
the patient apply the preparation with a glass highball stirring rod and to mas-
sage it into the skin for one to two minutes with the glass rod, about an hour
before retiring. Patients were observed at weekly intervals and if no scaling
or erythema was present they were instructed to apply the remedy in the morn-
ing as well as at night. The matinal application was preceded by soap and
water washing, and allowed to remain on for fifteen minutes while the patient
was dressing and breakfasting. It was then removed with a towel. The nightly
application also was preceded by soap and water washing, and was allowed to
remain on until morning. Depending upon the degree of reaction, the patient
was instructed to apply the remedy once daily, twice daily, three times daily
or, in some instances, especially during the first few weeks, three times weekly.
It was customary to prescribe two ounces of the liquid remedy.
Constipation, anemia, and other systemic disorders were regulated whenever
possible. A well-balanced diet was advised. Comedones were not expressed
or pustules opened. None of the conventional internal remedies for acne, such
as stannoyxyl, liver, calcium sulfide, vitamin A, vaccine, etc., were prescribed.
DEFINITION OF CURE AND IMPROVEMENT
The term cure was employed, when there were no acne lesions cr only an
occasional comedo, papule or pustule.
We purposely omitted estimating the degree or percentage of improvement
in our tables or summary. It appeared that the degree or percentage of improve-
ment was directly proportional to the number of weeks the treatment was used.
Improvement was usually noted after two weeks, occasionally after one week,
and then improvement increased with each week of additional treatment, so
that in a majority of patients, after about four months, the skin was either
free of lesions or almost so.
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Acne Comedo
TABLE 1
NO. AGE WEEKS TREATED RESULT
Females
1
2
3
4
5
6
7
8
9
10
11
12
13
11
12
12
13
14
14
14
14
14
15
15
16
31
36
4
11
6
6
7
9
9
12
32
28
9
4
improved
improved
improved
improved
improved
improved
improved
improved
improved
improved
well
improved
improved
Males
14 17 9 improved
TABLE 2
Average period of time to get well 28 weeks
Shortest " " " " " 28 weeks
Longest " 28 weeks
TABLE 3
Treated for average or longer period of time to get well
WELL IMPROVED NO CHANGE WORSE
ACE GROUP NO. WEEKS
m I m f in f in
11—14 1 36 0 0 1 0 0 0 0 0
15—20 2 28—32 1 0 1 0 0 0 0 0
21—30 0
Total 3 1 0 2 0 0 0 0 0
TABLE 4
Treated for less than average period of time to get well
AGE GROUP
11—14
15-20
21—31
NO. WEEKS
8 4—12
2 9
1 4
SMPROVED
m
8 0
1 1
1 0
NO CHANGE
I m
0 0
0 0
0 0
WORSE
I in
0 0
0 0
0 0
Total.... 11 10 1 0 0 0 0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
13
13
13
14
15
15
15
16
16
16
17
18
18
19
19
20
20
20
21
21
25
25
25
26
26
30
30
30
31
34
12
12
3
5
8
13
6
31
4
3
11
7
4
3
2
2
19
8
10
3
2
5
26
10
3
26
52
16
12
11
improved
improved
improved
improved
improved
well
improved
well
improved
improved
improved
improved
improved
improved
no change
improved
well
well
improved
improved
improved
improved
well
well
improved
well
well
well
well
improved
improved
improved
improved
improved
improved
improved
improved
improved
improved
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Acne Papulosa
TABLE 5
NO. AGE WEEKS TREATED RESULT
Females
Males
31
32
33
34
35
36
37
38
39
15
16
16
17
17
17
19
19
19
15
3
15
3
13
11
11
2
13
COMMENT
Atopy. Of a total of 130 patients 85 were questioned regarding a personal
or family history of atopy. Twenty-two (25.65%) patients gave such history.
Atopy did not prove a contraindication.
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Dermatitis Venenata. One female, thirty years old, with no personal or
family history of atopy developed dermatitis venenata after ten weeks of treat-
ment. The incidence of dermatitis venenata was 0.76%.
Recurrences. There were two recurrences, both females, one 14 years of age
with acne pustulosa, who required 23 weeks for a cure. She remained well for
7 months and then had a recurrence. The second patient, 19 years of age, with
acne indurata, required 33 weeks to be cured. She remained well for 5 months
and then had a recurrence. The incidence of recurrence was 4.5%.
TABLE 6
Average period of time to get well 21.3 weeksShortest " '' '' '' " 8 weeks
Longest " " " " " 52 weeks
TABLE 7
Treated for average or longer period of time to get well
AGE GROUP
13—14
15—20
21—34
Total
NO.
0
4
6
WEEKS
8—31
10—52
WELL
m
4 0
6 0
IMS'EOVED
f m
0 0
0 0
NO CHANGE
I m
0 0
0 0
WORSE
f m
0 0
0 0
10 10 0 0 0 0 0 0 0
TABLE 8
Treated for less than average period of time to get well
AGE GROUP
13—14
15—20
21—34
NO.
4
19
6
WEEKS
3—12
2—15
2—11
IMPROVED
m
4 0
9 9
6 0
NO CHANGE
I in
0 0
1 0
0 0
WORSE
I in
0 0
0 0
0 0
Total.... 29 19 9 1 0 0 0
Tables. For each type of acne treated, the following four tables are presented
on one page.
1) Number of patients treated, age, sex, number of weeks under observation
and the result (table 1).
2) Average, shortest, and longest period of time required for a cure (table 2).
3) Patients treated for average or longer periods of time subdivided according
to (table 3).
a) Age group
b) Number of patients in each age group
c) Number of weeks treated
d) Those cured, improved, etc. subdivided according to sex.
Acne Pustulosa
TABLE 9
NO. AGE WEEKS TREATED RESULT
Females
1 13 7 improved
2 14 23 well, recurred
3 14 12 no change
4 15 18 improved
5 16 14 well
6 16 10 well
7 17 5 improved
8 17 19 improved
9 17 3 improved
10 17 9 improved
11 18 10 well
12 18 32 well
13 18 16 improved
14 18 3 improved
15 18 3 improved
16 18 12 well
17 19 10 well
18 19 15 well
19 20 12 well
20 20 3 improved
21 20 12 well
22 20 4 improved
23 21 13 well
24 21 3 improved
25 21 8 well
26 21 12 well
27 22 5 improved
28 22 14 well
29 22 6 well
30 23 17 well
31 24 6 improved
32 24 10 well
33 26 16 well
34 29 10 well
35 30 13 well, dermatitis
36 30 13 well
37 31 8 improved
Males
38
39
40
41
42
43
44
45
46
47
48
49
13
15
15
16
16
17
17
17
18
20
21
21
4
3
14
19
6
13
1
6
4
10
9
4
improved
improved
well
improved
improved
improved
no change
improved
improved
well
improved
improved
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TABLE 10
Average period of time to get well 13.3 weeks
Shortest " " " " " " 6 weeks
Longest " " " " " " 32 weeks
TABLE 11
Treated for average or longer period of time to get well
317
AGE GROUP
13—14
15—20
21—31
NO.
1
15
11
WEEKS
23
10—32
6—17
WELL
m
1 0
9 2
11 0
IMPROVED
f in
0 0
2 2
0 0
NO CEANGE
f in
0 0
0 0
0 0
WORSE
f in
0 0
0 0
0 0
Total
-
27 21 2 2 2 0 0 0 0
TABLE 12
Treated for less thar average period of time to get well
IMPROVED NO
AGE GROUP NO. WEEKS
f m
13—14 3 2—7 1 1
15—20 13 1—12 8 4
21—31 6 3—9 4 2
Total.... 22 13 7
WORSE
in
0
0
0
0
Acne Indurata
TABLE 13
NO. AGE WEEKS TREATED RESULT
Females
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
18
18
18
19
19
20
21
23
23
25
26
26
30
30
35
36
4
9
10
6
33
7
4
81
9
10
3
8
9
17
3
7
improved
well
well
improved
well, recurred
improved
improved
improved
no change
improved
improved
improved
improved
improved
well
improved
improved
Males
18
19
21)
21
22
23
14
15
15
16
17
23
15
14
10
3
13
16
improved
well
well
improved
improved
well
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4) Patients treated for less than average period of time for a cure subdivided
similarly to table 3 (table 4).
TABLE 14
Average period of time to get well 15.5 weeks
Shortest " " " " " " 9 weeks
Longest " " " " " " 33 weeks
TABLE 15
Treated for average or longer period of time to get well
AGE GROUP
14
15—20
21—36
NO.
0
5
2
WEEKS
9—33
16—17
WELL
m
3 2
1 1
IMPROVED
f m
0 0
0 0
NO CRANGE
f m
0 0
0 0
WORSE
f m
0 0
0 0
Total 7 4 3 0 0 0 0 0 0
TABLE 16
Treated for le8s than average period of time to get well
AGE GROUP
14
15—20
21—36
NO.
1
6
9
WEEKS
15
4—15
1—10
IMPROVED
m
0 1
4 2
8 0
NO CUANGE
f m
0 0
0 0
1 0
WORSE
f m
0 0
0 0
0 0
Total.... 16 12 3 1 0 0 0
TABLE 17 TABLE 18
Acne erythematosa Acne cystica
NO. AGE TREATED RESULT NO. AGE RESULT
Female Female
1 26 10 improved 1 28
1
10 improved
2 39 4 well
3 40 5 well Male
2 16 12 well
Following these tables the final results in figures and percentages are given for
each variety of acne (tables 5 through 19), subdivided according to age groups.
A final table summarizes for each variety of acne the total number of pa-
TABLE 19
Results arranged according to age group
TEPE WELL IMPROVED NO CHANGE
Age—il to 14 years
Comedo
Papulosa
Pustolosa
Indurata
9
4
4
1
0
0
1 or 25%
0
9 or 100%
4 or 100%
2 or 50%
1 or 100%
0
0
1 or 25%
0
Total 18 1 or 5.5% 16 or 88.8% 1 or 5.5%
Age—iS to 20 years
Comedo
Papulosa
Pustulosa
Indurata
4
23
28
10
1 or 25%
4 or 17.3%
11 or 39.2%
5 or 50%
3 or 75%
18 or 78.2%
lOor 57.1%
5 or 50%
0
1 or 4.3%
ior3.5%
0
Total 65 21 or 32.3% 42 or 64% 2 or 3%
Age—21 to 36 years
Comedo
Papulosa
Pustulosa
Indurata
1
12
17
11
0
6 or 50%
11 or 64.7%
2 or 18.1%
1 or 100%
6 or 50%
6 or 35.3%
8 or 72.7%
0
0
0
1 or 9%
Total 41 19or46.3% 2lor 51.2% br 2.4%
TABLE 20
Patients treated for average or longer period of time to get well
PATIENTS TREATED AVERAGEPERIOD OP
TREATED
WEI.I. IMPROVED UNIMPROVED
Type Number
Comedo
Papulosa
Pustulosa
Indurata
Cystica
Erythematosa
3
10
27
7
1
3
weeks
28
21.3
13.3
15.5
12
4.5
1 or 33.3%
10 or 100%
23 or 85.1%
7 or 100%
1 or 100%
2 or 66.6%
2 or 66.6%
0 or 0.0%
4 or 14.8%
0 or 0.0%
0 or 0.0%
1 or 33.3%
0
0
0
0
0
0
Patients treated for less than average period of time to get well
PATIENTS TREATED PERIOD OP
TIME
TREATED
4 to 12
2 to 15
1 to 12
14 to 15
10
0
IMPROVED
11 or 100%
28 or 96.5%
2 or 90.9%
15 or 93.7%
1 or 100%
Oor 0.0%
UNIMPROVED
0 or 0.0%
1 or 3.4%
2 or 9.0%
1 or 6.2%
0 or 0.0%
OorO.0%
WORSE
0
0
0
0
0
0
Type
Comedo
Papulosa
Pustulosa
Indurata
Cystica
Erythematosa
Number
11
29
22
16
1
0
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tients, the average period of time required for a cure with the final results in
figures and percentages.
Because of the paucity of instances of erythematous and cystic acne vulgaris,
it is unnecessary to summarize, but the results certainly are most encouraging
as can be seen from the above tables.
SUMMARY
Acne Comedo. There were 14 patients with acne comedo, 13 females and one
male. They varied in age from 13 to 31 years; 9 were in the 11 to 14 year age
group, 4 in the 15 to 17 year age group and one was a 31 year old woman.
The 9 patients in the 11 to 14 year age group, all females, were treated for
from 4 to 36 weeks, with improvement directly proportional to the number of
weeks the remedy was used.
Of the 4 patients in the 15 to 17 year age group, 3 were females and one was a
male. Of the 3 females, one was cured in 28 weeks, while 2 who were treated
for 9 and 32 weeks improved proportionally to the length of time the prepara-
tion was used. The one male was treated for 9 weeks and showed moderate
improvement.
The 31 year old woman was treated for 4 weeks and showed some improve-
ment,
The average period of time to cure acne comedo was 28 weeks. Three pa-
tients were treated for 28 weeks or more. One was cured and 2 were markedly
improved.
Acne Papulosa. There were 39 patients with acne papulosa, 30 females and
9 males. They varied in age from 13 to 34 years; 4 were in the 13 to 14 year
age group, 23 in the 15 to 20 year group and 12 were from 21 to 34 years old.
The 4 patients in the 13 to 14 year age group, all females, were treated for
from 3 to 13 weeks with improvement increasing proportionally with the num-
ber of weeks the remedy was used.
Of the 23 patients in the 15 to 20 year age group, 14 were females and 9 were
males. Of the 14 females four were cured in 8, 13, 19 and 31 weeks, i.e. an aver-
age of 17* weeks; 9 were treated for from 2 to 15 weeks and improved in direct
proportion to the number of weeks the preparation was used, while one who was
treated for only 2 weeks exhibited no change. The nine males were treated for
from 2 to 15 weeks. None was cured but all showed proportionate improvement.
Of the 12 patients in the 21 to 34 age group, all were females. Six were
cured in 10, 12, 16, 26, 26, and 52 weeks, i.e. an average of 23* weeks. Six were
treated for from 2 to 11 weeks and all showed proportionate improvement.
Patients in the 15 to 20 year age group were cured in a shorter period of time
than the 21 to 34 year age group.
The average period of time to cure acne papulosa, disregarding age, was 21.3
weeks. Ten patients used the treatment for this length of time and all ten were
cured.
Acne Pustulosa. There were 49 patients with acne pustulosa, 37 females and
18 males. They varied in age from 13 to 31 years; 4 were in the 13 to 14 year
age group, 28 in the 15 to 20 year group and 17 in the 21 to 31 year group.
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Of the 4 patients in the 13 to 14 year group, 3 were females and one was a
male. Of the 3 females, one was cured in 23 weeks, one was improved at the
end of 7 weeks, while the third was treated for only 2 weeks with no change in
her acne. The 13 year old male was treated for 4 weeks and showed some im-
provement.
Of the 28 patients in the 15 to 20 year group, 19 were females and 9 were
males. Of the 19 females, 9 were cured in 10, 10, 10, 12, 12, 12, 14, 15, and
32 weeks, i.e. an average of 14-i weeks; 10 were treated for from 3 to 19
weeks with proportionate improvement. Of the 9 males, 2 were cured in 10
and 14 weeks, i.e. an average of 12 weeks; 6 were treated for only one week and
showed no improvement.
Of the 17 patients in the 21 to 31 age group, 15 were females and 2 were males.
Of the 15 females, 11 were cured in 6, 8, 10, 10, 12, 13, 13, 13, 14, 16, and 17
weeks, i.e. an average of 12 weeks; 4 were treated for from 3 to 8 weeks and
showed proportionate improvement. The two males were treated 4 and 9
weeks and were proportionately improved.
In the 13 to 14 year group one female was cured in 23 weeks. In the 15 to
20 year group, 9 females were cured in an average of 14 weeks, while 2 males
were cured in an average of 12 weeks. In the 21 to 31 year age group, 11 fe-
males were cured in an average of 12 weeks.
Disregarding sex, patients in the 15 to 20 year group were cured in an aver-
age of 13 weeks, and patients in the 21 to 31 year group were cured in an aver-
age of 12 weeks.
Disregarding age and sex, the average period of time to cure acne pustulosa
was 13 weeks. Twenty-seven used the preparation for this length of time and
23 (85.1 %) were cured and 4 (14.8%) were markedly improved.
Acne Indurata. There were 23 patients in this group, 17 females and 6
males. They varied in age from 14 to 36 years; one was 14 and there were 11
each from 15 to 20 and from 21 to 36 years old.
The 14 year old boy was treated for 15 weeks with substantial improvement.
Of the 11 patients in the 15 to 20 year age group, 7 were females and 4 were
males. Of the seven females, 3 were cured in 9, 10, and 33 weeks, i.e. an aver-
age of 17 weeks; 4 were treated for from 4 to 7 weeks and were proportionately
improved. Of the 4 males, 2 were cured in 10 and 14 weeks, while 2 were treated
for from 3 to 13 weeks with improvement in direct proportion to the length of
time the treatment was used.
Of the 11 patients in the 21 to 36 age group, 10 were females and one was a
male. Of the 10 females, one was cured in 17 weeks; 8 were treated for from
3 to 10 weeks and showed proportionate improvement, while one was treated
for only 1 weeks and showed no change. The one male patient in this group
was cured in 16 weeks.
In the 15 to 20 year age group, females were cured on an average of 171
weeks, while it required only 12 weeks for the males.
In the 21 to 36 year age group one female was cured in 17 weeks and one male
in 16 weeks.
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Disregarding sex, patients in the 15 to 20 year age group required 15 weeks
to get well, while those in the 21 to 36 year group required 16 weeks.
The average period of time to cure acne indurata, regardless of age or sex,
was 15.5 weeks. Ten patients used the preparation this period of time and
all were cured.
CONCLUSIONS
1. A total of 130 patients with various clinical types of acne vulgaris were
treated with "Intraderm Sulphur". Of these 101 were females and 29 were
males.3
2. The average period of time to cure each variety of acne vulgaris, and the
percentage of cures and improvement are given in tabular form.
3. The average period of time to cure acne vulgaris (obtained by combining
the average periods of time required to cure each type) was 15.38 weeks.
4. The total number of patients using the remedy for 15 or more weeks was
49, of whom 44 (89.79%) were cured, and 5 (10.21%) were greatly improved.
None was made worse or was unimproved.
5. There were 2 recurrences after cure, an incidence of 4.5%.
6. One patient developed dermatitis venenata caused by the remedy, an
incidence of 0.76%.
7. Patients with a personal or family history of atopy can use the preparation
with no untoward results.
8. The ease of application and removal, and the absence of messiness inci-
dental to the use of a lotion or salve are distinct advantages.
9. "Intraderm Sulphur" is a valuable preparation in the treatment of all
types of acne vulgaris and appears to be superior to the conventional remedies
used for the treatment of this disease. The percentage of cures and the length
of time required for a cure, compare favorably with x-ray treatment.
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